Resources with keywords: chikungunya



Risk of death following chikungunya virus disease in the 100 Million Brazilian Cohort, 2015–18: a matched cohort study and self-controlled case series
The Lancet
8 February 2024

Cerqueira-Silva T, et al
Chikungunya virus disease is associated with an increased risk of death for up to 84 days after symptom onset, including deaths from cerebrovascular diseases, ischaemic heart diseases, and diabetes.

FDA Approves First Vaccine to Prevent Disease Caused by Chikungunya Virus
FDA

From FDA’s Release: Ixchiq is administered as a single dose by injection into the muscle. It contains a live, weakened version of the chikungunya virus and may cause symptoms in the vaccine recipient similar to those experienced by people who have chikungunya disease.

IXCHIQ
FDA

Vaccine Information

Pathogen Safety Data Sheets: Infectious Substances – Chikungunya virus
Public Health Agency of Canada

Reference document on Chikungunya Virus

Chikungunya: CDC Yellow Book 2024

This chapter includes information on the agent, transmission, diagnosis, treatment, prevention, epidemiology

Go to Top